AMAT vs SPRO · P/E 56, rev $24.04B vs P/E 9.6, rev $258.0K
Applied Materials Inc (AMAT) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Applied Materials Inc (AMAT) is a semiconductor equipment & materials company listed on NASDAQ.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported AMAT revenue for 2026-07-26 was $24.04B. Net income was $7.37B. AMAT currently screens at market cap $470.75B and trailing P/E 55.8.
Latest reported SPRO revenue for 2026-06-30 was $258.0K. Net income was -$16.8M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
AMAT currently screens at market cap $470.75B and trailing P/E 55.8. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the AMAT and SPRO stock pages for the full models.
Not investment advice.